Bridgefront Capital’s Axsome Therapeutics AXSM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,555	Closed	-$893K	–	624
2024 Q4	$893K	Buy	+10,555	New	+$893K	0.3%	79
2021 Q2	–	Sell	-9,257	Closed	-$524K	–	605
2021 Q1	$524K	Buy	+9,257	New	+$524K	0.16%	215